South and Central America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country

TIPRE00018218 | Pages: 99 | Medical Device | Jan 2021 | Type: Regional | Status: Published

Market Introduction

Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period. With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections. In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases.


Get more information on this report :



Market Overview and Dynamics

The South & Central America patient controlled injectors market is expected to reach US$ 208.66 million by 2027 from US$ 93.28 million in 2019. The market is anticipated to grow at a CAGR of 10.6% during 2019–2027. The increasing chronic diseases prevalence, and rising patient compliance are the major factors expected to boost the growth of the patient controlled injectors market in South & Central America. However, the market is likely to get impacted by the risk factor such as preference of alternative drug delivery during the forecast period.

Key Market Segments

In terms of products, the electronic injector segment accounted for the largest share of the South & Central America patient controlled injectors market in 2019. In terms of application, the cancer treatment segment accounted for the largest share of the South & Central America patient controlled injectors market in 2019. In terms of distribution channel, the hospital pharmacies segment accounted for the largest share of the South & Central America patient controlled injectors market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the South & Central America patient controlled injectors market report are the World Health Organization (WHO), Global Burden of Disease (GBD), International Diabetes Federation (IDF), and others.

Reasons to buy report

  • It provides understanding of the South & Central America, patient controlled injectors market landscape and identifies patient controlled injectors market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America patient controlled injectors market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the patient controlled injectors market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of patient controlled injectors market performance of various segments pertaining to the South & Central America patient controlled injectors market.
  • It provides patient controlled injectors market revenue forecast of the market based on various segments for the period from 2019 to 2027.

SOUTH & CENTRAL AMERICA PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION

By Products

  • Electronic Wearable Injector
  • Mechanical Wearable Injector
  • Infusion Pumps

 

By Application

  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment
  • Others

 

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Mail Order Pharmacies

 

By Country

  • Brazil
  • Argentina
  • Rest of South & Central America

 

Company Profiles

  • Johnson and Johnson Services, Inc.
  • Sensile Medical AG (Gerresheimer AG)
  • F. HOFFMANN-LA ROCHE LTD
  • Ypsomed AG
  • Westbourne Medical Limited

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Patient Controlled Injectors Market – By Product

1.3.2        South & Central America Patient Controlled Injectors Market – By Application

1.3.3        South & Central America Patient Controlled Injectors Market – By Distribution Channel

1.3.4        South & Central America Patient Controlled Injectors Market – By Country

2.           South & Central America Patient Controlled Injectors Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Patient Controlled Injectors Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Patient Controlled Injectors Market - South & Central America PEST Analysis

4.3         Expert Opinion

5.           South & Central America Patient Controlled Injectors Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Rising Patient Compliance

5.2         Market Restraints

5.2.1        Preference of Alternative Drug Delivery

5.3         Market Opportunities

5.3.1        Technological Advancements and Design Development

5.4         Future Trends

5.4.1        Consolidation of Market

5.5         Impact Analysis

6.           Patient Controlled Injectors Market – South & Central America Analysis

6.1         South & Central America Patient Controlled Injectors Market Revenue Forecasts and Analysis

7.           South & Central America Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product

7.1         Overview

7.2         South & Central America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)

7.2.1        South & Central America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3         Electronic Injector

7.3.1        Overview

7.3.2        South & Central America Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Mechanical Injectors

7.4.1        Overview

7.4.2        South & Central America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Infusion Pumps

7.5.1        Overview

7.5.2        South & Central America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

8.           South & Central America Patient Controlled Injectors Market Analysis – By Application

8.1         Overview

8.2         South & Central America Patient Controlled Injectors Market, By Application 2019-2027 (%)

8.2.1        South & Central America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Cancer Treatment

8.3.1        Overview

8.3.2        South & Central America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)

8.4         Autoimmune Disease

8.4.1        Overview

8.4.2        South & Central America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Blood Disorders Treatment

8.5.1        Overview

8.5.2        South & Central America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           South & Central America Patient Controlled Injectors Market Analysis – By Distribution Channel

9.1         Overview

9.2         South & Central America Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)

9.2.1        South & Central America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

9.3         Hospital Pharmacies

9.3.1        Overview

9.3.2        South & Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4         Retail Pharmacies

9.4.1        Overview

9.4.2        South & Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5         Mail Order Pharmacies

9.5.1        Overview

9.5.2        South & Central America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      South & Central America Patient Controlled Injectors Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     South and Central America: Patient Controlled Injectors Market – Revenue and Forecast to 2027  (USD Million)

10.1.3     South and Central America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     South and Central America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.1.5     South and Central America Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6     South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)

10.1.7     Brazil: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Brazil: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Brazil Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Brazil Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.7.4       Brazil Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8     Argentina: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Argentina: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Argentina Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Argentina Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.8.4       Argentina Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9     Rest of South and Central America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Rest of South and Central America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Rest of South and Central America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       Rest of South and Central America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

10.1.9.4       Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on South & Central America Patient Controlled Injectors Market

11.1      South & Central America: Impact Assessment of COVID-19 Pandemic

12.        Company Profiles

12.1      Sensile Medical AG (Gerresheimer AG)

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. HOFFMANN-LA ROCHE LTD.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Ypsomed AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Westbourne Medical Limited

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Johnson and Johnson Services, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             South & Central America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.             South & Central America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             South & Central America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 4.             South and Central America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             South and Central America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 6.             South and Central America Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             Brazil Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Brazil Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 9.             Brazil Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.          Argentina Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.          Argentina Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 12.          Argentina Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Rest of South and Central America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.          Rest of South and Central America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)

Table 15.          Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 16.          Glossary of Terms, Patient Controlled Injectors Market

LIST OF FIGURES

Figure 1.           Patient Controlled Injectors Market Segmentation

Figure 2.           South & Central America Patient Controlled Injectors Market Overview

Figure 3.           Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South & Central America Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)

Figure 6.           Patient Controlled Injectors Market - South & Central America PEST Analysis

Figure 7.           Patient Controlled Injectors Market Impact Analysis of Driver and Restraints

Figure 8.           South & Central America Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           South & Central America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)

Figure 10.        South & Central America Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        South & Central America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        South & Central America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        South & Central America Patient Controlled Injectors Market, by Application 2019 & 2027 (%)

Figure 14.        South & Central America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        South & Central America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        South & Central America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        South & Central America Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)

Figure 19.        South & Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        South & Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        South & Central America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        South and Central America: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        South and Central America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)

Figure 25.        Brazil: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Argentina: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Rest of South and Central America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact Of COVID-19 Pandemic in South and Central America Market

  1. Johnson and Johnson Services, Inc.
  2. Sensile Medical AG (Gerresheimer AG)
  3. F. HOFFMANN-LA ROCHE LTD
  4. Ypsomed AG
  5. Westbourne Medical Limited
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America patient controlled injectors market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000